Several studies have shown that P38 active form (i.e., pP38) is associated with neuritic Aβ‐amyloid plaques and tau NFT in postmortem brains of AD patients and that P38 activation occurs at very early stage of the disease (Reynolds et al., 2000; Peel et al., 2004). This evidence concerns the gene MAPK14 and Alzheimer disease.